![Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants](https://www.frontiersin.org/files/Articles/701501/fimmu-12-701501-HTML/image_m/fimmu-12-701501-g001.jpg)
Frontiers | SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Adventist Health - #Fact: None of the COVID-19 vaccines authorized in the United States contain any animal products. Some vaccines have historically used pork gelatin as a stabilizer, but gelatin is NOT
![nychealthy on Twitter: "What's in a #COVID19 vaccine? Not much! In addition to the messenger (such as mRNA or the modified adenovirus), the vaccines contain ingredients like lipids, salts, sugar and certain nychealthy on Twitter: "What's in a #COVID19 vaccine? Not much! In addition to the messenger (such as mRNA or the modified adenovirus), the vaccines contain ingredients like lipids, salts, sugar and certain](https://pbs.twimg.com/media/FHEZVrOXoAkqjig.jpg)
nychealthy on Twitter: "What's in a #COVID19 vaccine? Not much! In addition to the messenger (such as mRNA or the modified adenovirus), the vaccines contain ingredients like lipids, salts, sugar and certain
![Vaccines | Free Full-Text | Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens Vaccines | Free Full-Text | Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens](https://www.mdpi.com/vaccines/vaccines-09-00252/article_deploy/html/images/vaccines-09-00252-g005.png)
Vaccines | Free Full-Text | Development of a Potent Stabilizer for Long-Term Storage of Foot-and-Mouth Disease Vaccine Antigens
![Explained: Why RNA vaccines for Covid-19 raced to the front of the pack | MIT News | Massachusetts Institute of Technology Explained: Why RNA vaccines for Covid-19 raced to the front of the pack | MIT News | Massachusetts Institute of Technology](https://news.mit.edu/sites/default/files/images/202012/MIT-mRNA-vaccines-explainer-01-PRESS.jpg)
Explained: Why RNA vaccines for Covid-19 raced to the front of the pack | MIT News | Massachusetts Institute of Technology
![Vaccines | Free Full-Text | Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities Vaccines | Free Full-Text | Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities](https://www.mdpi.com/vaccines/vaccines-09-01490/article_deploy/html/images/vaccines-09-01490-g001.png)